• Katherine A Young and Daniel F Dilling.
• Department of Pulmonary and Critical Care, Loyola University Medical Center, Maywood, IL.
• Chest. 2019 Mar 1; 155 (3): 465-473.

AbstractThe field of lung transplant has made significant advances over the last several decades. Despite these advances, morbidity and mortality remain high when compared with other solid organ transplants. As the field moves forward, the speed by which progress can be made will in part be determined by our ability to overcome several stumbling blocks, including donor shortage, proper selection of candidates, primary graft dysfunction, and chronic lung allograft dysfunction. The advances and developments surrounding these factors will have a significant impact on shaping the field within the coming years. In this review, we look at the current climate (ripe for expanding the donor pool), new technology (ex vivo lung perfusion and bioengineered lungs), cutting-edge innovation (novel biomarkers and new ways to treat infected donors), and evidence-based medicine to discuss current trends and predict future developments for what we hope is a bright future for the field of lung transplantation.Copyright © 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

14 keywords...

hide…